Journal article icon

Journal article

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

Abstract:

Aims/hypothesis: Epidemiological studies have generated conflicting findings on the relationship between glucose-lowering medication use and cancer risk. Naturally occurring variation in genes encoding glucose-lowering drug targets can be used to investigate the effect of their pharmacological perturbation on cancer risk.

Methods: We developed genetic instruments for three glucose-lowering drug targets (peroxisome proliferator activated receptor γ [...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1007/s00125-023-05925-4

Authors


Contributors

Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Role:
Contributor


More from this funder
Funder identifier:
https://ror.org/054225q67
Grant:
29017
29019
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MR/M012190/1


Publisher:
Springer
Journal:
Diabetologia More from this journal
Volume:
66
Issue:
8
Pages:
1481-1500
Place of publication:
Germany
Publication date:
2023-05-12
Acceptance date:
2023-03-13
DOI:
EISSN:
1432-0428
ISSN:
0012-186X
Pmid:
37171501

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP